title: [Stereotactic intracranial radiotherapy: dose prescription].
abstract: The aim of this article was the study of the successive steps permitting the prescription of dose in stereotactic intracranial radiotherapy, which includes radiosurgery and fractionated stereotactic radiotherapy. The successive steps studied are: the choice of stereotactic intracranial radiotherapy among the therapeutic options, based on curative or palliative treatment intent, then the selection of lesions according to size/volume, pathological type and their number permitting the choice between radiosurgery or fractionated stereotactic radiotherapy, which have the same methodological basis. Clinical experience has determined the level of dose to treat the lesions and limit the irradiation of healthy adjacent tissues and organs at risk structures. The last step is the optimization of the different parameters to obtain a safe compromise between the lesion dose and healthy adjacent structures. Study of dose-volume histograms, coverage indices and 3D imaging permit the optimization of irradiation. For lesions close to or included in a critical area, the prescribed dose is planned using the inverse planification method. Implementation of the successively described steps is mandatory to insure the prescription of an optimized dose. The whole procedure is based on the delineation of the lesion and adjacent healthy tissues. There are sometimes difficulties to assess the delineation and the volume of the target, however improvement of local control rates and reduction of secondary effects are the proof that the totality of the successive procedures are progressively improved. In practice, stereotactic intracranial radiotherapy is a continually improved treatment method, which constantly benefits from improvements in the choice of indications, imaging, techniques of irradiation, planification/optimization methodology and irradiation technique and from data collected from prolonged follow-up.
authors.affiliation: Service de radiothérapie-oncologie, hôpital Tenon, 4 rue de la Chine, Paris, France. michel.schlienger@tnn.aphp.fr
authors.forename: M
authors.initials: M
authors.lastname: Schlienger
authors.forename: E
authors.initials: E
authors.lastname: Lartigau
authors.forename: F
authors.initials: F
authors.lastname: Nataf
authors.forename: F
authors.initials: F
authors.lastname: Mornex
authors.forename: I
authors.initials: I
authors.lastname: Latorzeff
authors.forename: A
authors.initials: A
authors.lastname: Lisbona
authors.forename: M
authors.initials: M
authors.lastname: Mahé
mesh_terms: D001932:Brain Neoplasms / Q000473:pathology / Q000601:surgery*; D006801:Humans; D021621:Imaging, Three-Dimensional; D002538:Intracranial Arteriovenous Malformations / Q000473:pathology / Q000601:surgery; D008279:Magnetic Resonance Imaging; D058958:Organs at Risk; D016634:Radiosurgery; D011879:Radiotherapy Dosage